Southeast BIO announced the keynote speakers and featured panelists for the Ninth Annual Southeastern BIO Investor Forum. The Investor Forum, scheduled for Nov. 7-8, 2007 at the Pinehurst Resort in Pinehurst will feature remarks from more than 14 industry leaders.
The conference's opening keynote panel session, "What Emerging Companies Want to Know," will feature business development leaders from the big pharma, big biotech and medical device industries, including:
- Rick Anderson, company group chairman, Johnson & Johnson and worldwide franchise chairman, Cordis Corporation;
- Leslie Boyd, vice president of Scientific Licensing, GlaxoSmithKline;
- Edward T. Mathers, executive vice president, corporate development and Venture, MedImmune; and
- Kenneth Lee, general partner, Hatteras Venture Partners (Moderator).
The first day of the conference will also include a special patent law-focused panel to address "The Impact of the Recent Patent Rule Changes on Emerging Companies and Technology Transfer," featuring:
- Margaret Bolce Brivanlou, partner, King and Spalding;
- Jamie Greene, partner, Kilpatrick Stockton;
- Todd Sherer, associate vice president research and director Office of Technology Transfer, Emory University;
- Doug Gooding, CEO, Regado Biosciences; and
- Allen Baum, partner, Hutchison Law Group PLLC and Immediate Past President, Licensing Executives Society (USA & Canada) (Moderator).
Matthew Emmens will serve as a conference keynote speaker, discussing "Global Biopharmaceutical Companies: The Challenges Ahead." Emmens is the CEO and chairman of the management committee at Shire Pharmaceuticals Group.